ZIMMER BIOMET HOLDINGS, INC.·4

Feb 27, 4:02 PM ET

Stellato Paul A 4

Research Summary

AI-generated summary

Updated

Zimmer Biomet VP Paul Stellato Receives RSUs; 402 Shares Withheld

What Happened

  • Paul A. Stellato, VP, Controller and CAO of Zimmer Biomet (ZBH), had 820 restricted stock units (RSUs vest) converted into 820 common shares on Feb 25, 2026. To satisfy tax withholding, the company withheld 402 of those shares (disposed) at an implied per-share value of $99.51, equal to ~$40,003. The RSU conversion shows no exercise price ($0), so Stellato did not pay to receive the shares; net shares received = 820 − 402 = 418.

Key Details

  • Transaction date: February 25, 2026.
  • Conversion/exercise entry: 820 shares @ $0.00 (conversion of RSUs).
  • Tax withholding (disposition): 402 shares withheld @ $99.51 = $40,003 (company withholding to satisfy tax liabilities).
  • Net new shares delivered to insider: 418 shares.
  • Footnotes: F1 confirms shares were withheld by the company to cover taxes; F2 notes one‑third of the RSUs vested on 2/25/2026, with remaining RSUs vesting half on 2/25/2027 and 2/25/2028.
  • Shares owned after the transaction: not disclosed in the filing.
  • Filing status: reported on Form 4 filed Feb 27, 2026 (appears timely).

Context

  • This was not an open-market buy or sell for cash but a routine RSU vesting with a company share‑withholding to cover tax obligations (common practice). The $0 exercise price and simultaneous withholding indicate a conversion/settlement of RSUs rather than a paid option exercise. Such tax-withholding disposals are administrative and do not necessarily indicate insider sentiment.